Skip to main content

Find Clinical Trials

Home
Conditions
Triple Negative Breast Neoplasms

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies

Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Not Yet Recruiting

TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer

NCT07271992

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

NCT07256964

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis

NCT07246759

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +41 more
Locations: Heidelberg University Hospital Heidelberg, Germany

Intituto Europeo di Oncologia SRL Milan, Italy

Virgen Macarena University Hospital - Servicio Andaluz de Salud Seville, Spain

View Trial Details

Not Yet Recruiting

Sac-TMT Combined With Toripalimab for First-line Treatment of PD-L1 Positive a/mTNBC

NCT07244874

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

NCT07187674

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers

NCT07080619

Conditions: Breast Diseases, Breast Neoplasms, HR+ Breast Cancer, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

NCT07161791

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers

NCT05806385

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC

NCT07040644

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations: Sun Yat-sen Memorial Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Sacituzumab Tirumotecan Plus Tagitanlimab in Previously Treated Locally Advanced or Metastatic Triple Negative Breast Cancer

NCT07153965

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details